Jacky C. Chan

Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors' reply.

Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors' reply.

Journal: AIDS (London, England)

Published: September 02, 2022

Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong.

Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong.

Journal: Emerging infectious diseases

Published: September 01, 2022

Hong Kong Drug Allergy Delabelling Initiative (HK-DADI) consensus statements for penicillin allergy testing by nonallergists.

Hong Kong Drug Allergy Delabelling Initiative (HK-DADI) consensus statements for penicillin allergy testing by nonallergists.

Journal: Frontiers in allergy

Published: June 20, 2022

Surrogate neutralization responses following severe acute respiratory syndrome coronavirus 2 vaccination in people with HIV: comparison between inactivated and mRNA vaccine.

Surrogate neutralization responses following severe acute respiratory syndrome coronavirus 2 vaccination in people with HIV: comparison between inactivated and mRNA vaccine.

Journal: AIDS (London, England)

Published: April 25, 2022

Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community Outbreak.

Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community Outbreak.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 19, 2022

Probable Animal-to-Human Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant AY.127 Causing a Pet Shop-Related Coronavirus Disease 2019 (COVID-19) Outbreak in Hong Kong.

Probable Animal-to-Human Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant AY.127 Causing a Pet Shop-Related Coronavirus Disease 2019 (COVID-19) Outbreak in Hong Kong.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 21, 2022

Coronavirus Disease 2019 Messenger RNA Vaccines Associated With Delayed Onset of Breakthrough Infections and Fewer Radiographic Abnormalities.

Coronavirus Disease 2019 Messenger RNA Vaccines Associated With Delayed Onset of Breakthrough Infections and Fewer Radiographic Abnormalities.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 15, 2021

Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients.

Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 12, 2021

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections.

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections.

Journal: bioRxiv : the preprint server for biology

Published: June 09, 2020

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.

Journal: Science (New York, N.Y.)

Published: May 05, 2020

Presumed COVID-19 index case on diamond princess cruise ship and evacuees to Hong Kong.

Presumed COVID-19 index case on diamond princess cruise ship and evacuees to Hong Kong.

Journal: Journal of travel medicine

Published: April 09, 2020

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.

Journal: Lancet (London, England)

Published: April 03, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026